As of Oct 15
| +2.55 / +1.47%|
The 19 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Inc have a median target of 217.00, with a high estimate of 254.00 and a low estimate of 183.00. The median estimate represents a +23.20% increase from the last price of 176.14.
The current consensus among 24 polled investment analysts is to Buy stock in Vertex Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.